Clinical Trial Update: The Real World Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China

View source ↗

Summary

Real-world study evaluating zanubrutinib for chronic lymphocytic leukemia in China; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• BRUKINSA (ZANUBRUTINIB)

Snippet

Sponsor: Peking University People's Hospital | Conditions: CLL | Status: NOT_YET_RECRUITING